Options for prostate cancer after curative treatment failure

Author：  

Publisher： Adis International

ISSN： 1173-8324

Source： Inpharma, Vol.1, Iss.1276, 2001-01, pp. : 4-4

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Pharmacoeconomics of Available Treatment Options for Metastatic Prostate Cancer

By Zeliadt Steven B.   Penson David F.  

PharmacoEconomics, Vol. 25, Iss. 4, 2007-01 ,pp. : 309-327

Adis International

Access to resources Recommend Favorite

Treatment Options in Hormone-Refractory Prostate Cancer: Current and Future Approaches

By Harris K.A.   Reese D.M.  

Drugs, Vol. 61, Iss. 15, 2001-01 ,pp. : 2177-2192

Adis International

Access to resources Recommend Favorite

Adjuvant Therapy in Prostate Cancer: Patient Identification and Treatment Options

By Syed S.   Tolcher A.   Troyer D.   Furman J.   Leach R.   Thompson I.M.  

UroOncology, Vol. 4, Iss. 3-4, 2004-09 ,pp. : 119-126

Ashgate Publishing Ltd

Access to resources Recommend Favorite

Treatment options in renal cancer

By  

Inpharma, Vol. 1, Iss. 1394, 2003-01 ,pp. : 5-5

Adis International

Access to resources Recommend Favorite

Treatment options for esophageal cancer

By Murphy Thomas J   Ravi Narayamasamy   Reynolds John V  

Expert Opinion on Pharmacotherapy, Vol. 9, Iss. 18, 2008-12 ,pp. : 3197-3210

Informa Healthcare

Access to resources Recommend Favorite